Relay Therapeutics Inc
NASDAQ:RLAY
Balance Sheet
Balance Sheet Decomposition
Relay Therapeutics Inc
Relay Therapeutics Inc
Balance Sheet
Relay Therapeutics Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
422
|
42
|
448
|
280
|
152
|
144
|
124
|
|
| Cash Equivalents |
422
|
42
|
448
|
280
|
152
|
144
|
124
|
|
| Short-Term Investments |
0
|
314
|
230
|
678
|
847
|
606
|
657
|
|
| Total Receivables |
0
|
0
|
83
|
5
|
5
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
83
|
5
|
5
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
3
|
5
|
9
|
13
|
15
|
20
|
28
|
|
| Total Current Assets |
424
|
361
|
770
|
976
|
1 020
|
770
|
809
|
|
| PP&E Net |
4
|
32
|
29
|
27
|
75
|
69
|
58
|
|
| PP&E Gross |
4
|
32
|
29
|
27
|
75
|
69
|
58
|
|
| Accumulated Depreciation |
5
|
7
|
11
|
14
|
18
|
24
|
29
|
|
| Intangible Assets |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
3
|
3
|
3
|
2
|
|
| Total Assets |
429
N/A
|
393
-8%
|
800
+103%
|
1 008
+26%
|
1 100
+9%
|
844
-23%
|
871
+3%
|
|
| Liabilities | ||||||||
| Accounts Payable |
5
|
7
|
6
|
8
|
11
|
9
|
14
|
|
| Accrued Liabilities |
2
|
5
|
7
|
15
|
25
|
19
|
26
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
28
|
2
|
10
|
|
| Total Current Liabilities |
7
|
12
|
14
|
24
|
64
|
30
|
51
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
24
|
23
|
86
|
86
|
62
|
43
|
|
| Total Liabilities |
7
N/A
|
36
+382%
|
37
+2%
|
111
+203%
|
150
+35%
|
92
-39%
|
94
+2%
|
|
| Equity | ||||||||
| Common Stock |
532
|
538
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
114
|
190
|
404
|
768
|
1 059
|
1 401
|
1 738
|
|
| Additional Paid In Capital |
3
|
9
|
1 167
|
1 667
|
2 019
|
2 153
|
2 517
|
|
| Other Equity |
0
|
0
|
0
|
1
|
10
|
0
|
1
|
|
| Total Equity |
421
N/A
|
357
-15%
|
763
+114%
|
898
+18%
|
950
+6%
|
752
-21%
|
778
+3%
|
|
| Total Liabilities & Equity |
429
N/A
|
393
-8%
|
800
+103%
|
1 008
+26%
|
1 100
+9%
|
844
-23%
|
871
+3%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
87
|
87
|
90
|
108
|
121
|
127
|
168
|
|